{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:21:54Z","timestamp":1780708914784,"version":"3.54.1"},"reference-count":13,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cephalalgia"],"published-print":{"date-parts":[[2000,6]]},"abstract":"<jats:p>The efficacy and tolerability of rizatriptan (MAXALT\u2122) and zolmitriptan (ZOMIG\u2122) were compared in a randomized, double\u2013blind, double\u2013dummy, stratified (on prior use of rizatriptan and\/or zolmitriptan), placebo\u2013controlled, single attack study in 766 patients. Rizatriptan tended to provide freedom from pain sooner than zolmitriptan (hazard ratio 1.26, P = 0.075), acting within 60 min following dosing. More patients were pain free at 2 h on rizatriptan than on zolmitriptan (43.2% vs. 35.6%, P = 0.041), while headache relief at 2 h was similar (70.5% vs. 66.8%). At 2 h, fewer patients on rizatriptan had symptoms of photophobia (35.6% vs. 43.5%, P = 0.029) and nausea (25.2% vs. 32.5%, P = 0.046), and more patients on rizatriptan had normal function (45.4% vs. 37.0%, P = 0.025) than zolmitriptan. Headache recurred in 28% of patients taking rizatriptan, 29% taking zolmitriptan and 26% taking placebo. Both active treatments were effective compared to placebo and were well tolerated. The most common side\u2013effects with rizatriptan were asthenia\/fatigue, somnolence and dizziness, while the most common side\u2013effects with zolmitriptan were asthenia\/fatigue and dizziness.<\/jats:p>","DOI":"10.1046\/j.1468-2982.2000.00069.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T07:07:12Z","timestamp":1047366432000},"page":"455-461","source":"Crossref","is-referenced-by-count":65,"title":["Comparison of Rizatriptan 10 Mg vs. Zolmitriptan 2.5 Mg in the Acute Treatment of Migraine"],"prefix":"10.1177","volume":"20","author":[{"given":"J","family":"Pascual","sequence":"first","affiliation":[{"name":"University Hospital Marqu\u00e9s de Valdecilla, Santander, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Vega","sequence":"additional","affiliation":[{"name":"Hospital San Jos\u00e9, Santa F\u00e9 de Bogot\u00e1, Colombia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u2013C","family":"Diener","sequence":"additional","affiliation":[{"name":"Neurologische Universit\u00e4tsklinik Essen, Essen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Allen","sequence":"additional","affiliation":[{"name":"Merck & Co. Inc., Whitehouse Station, NJ, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Vrijens","sequence":"additional","affiliation":[{"name":"International Institute for Drug Development, Brussels, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Patel","sequence":"additional","affiliation":[{"name":"Merck & Co. Inc., Whitehouse Station, NJ, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Group the Rizatriptan\u2013zolmitriptan Study","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2000,6,1]]},"reference":[{"key":"bibr1-j.1468-2982.2000.00069.x","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.1998.3804281.x"},{"key":"bibr2-j.1468-2982.2000.00069.x","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.3.773"},{"key":"bibr3-j.1468-2982.2000.00069.x","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.1998.3810737.x"},{"key":"bibr4-j.1468-2982.2000.00069.x","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.1998.3810764.x"},{"key":"bibr5-j.1468-2982.2000.00069.x","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.1998.3810748.x"},{"key":"bibr6-j.1468-2982.2000.00069.x","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.49.5.1219"},{"key":"bibr7-j.1468-2982.2000.00069.x","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1468-2982.1988.0801001.x","volume":"8","author":"Headache Classification Committee of the International Headache Society.","year":"1988","journal-title":"Cephalalgia"},{"key":"bibr8-j.1468-2982.2000.00069.x","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1995.hed3506320.x"},{"key":"bibr9-j.1468-2982.2000.00069.x","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1995.hed3506330.x"},{"key":"bibr10-j.1468-2982.2000.00069.x","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/60.2.267"},{"key":"bibr11-j.1468-2982.2000.00069.x","doi-asserted-by":"publisher","DOI":"10.2307\/2529588"},{"key":"bibr12-j.1468-2982.2000.00069.x","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/75.4.800"},{"key":"bibr13-j.1468-2982.2000.00069.x","unstructured":"13 International Headache Society. Guidelines of Controlled Trials of Drugs in Migraine. IHS Members' Handbook. Oslo, Norway: Scandinavian University Press, 1998: 111\u20133."}],"container-title":["Cephalalgia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1046\/j.1468-2982.2000.00069.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1046\/j.1468-2982.2000.00069.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1046\/j.1468-2982.2000.00069.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:40:32Z","timestamp":1777387232000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1046\/j.1468-2982.2000.00069.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["10.1046\/j.1468-2982.2000.00069.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1468-2982.2000.00069.x","relation":{},"ISSN":["0333-1024","1468-2982"],"issn-type":[{"value":"0333-1024","type":"print"},{"value":"1468-2982","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,6]]}}}